Ross Feller Casey has filed another major lawsuit alleging breast implants caused a rare form of cancer known as BIA-ALCL, or Breast Implant-Associated Anaplastic Large Cell Lymphoma.
In the latest suit, Ross Feller Casey alleges that breast implant maker Allegran, Inc. recklessly failed to warn consumers of the hazards of the implants and did not comply with product-safety studies that were mandated by the U.S. Food and Drug Administration.
The suit was filed last week in the Superior Court of New Jersey, Middlesex County on behalf of Michele Rea, of Fairfax, Virginia. Rea underwent reconstructive surgery for a partial mastectomy in 2011. About five years later, she was diagnosed with anaplastic large cell lymphoma, which was caused by a Natrelle Style 410 implant made by Allergan, Inc., the suit alleges.
Allergan fraudulently conveyed false and misleading information “and concealed the risks of serious adverse events associated with its breast implants from plaintiffs, the public, physicians, and other healthcare providers,” the lawsuit said.
In April, Ross Feller Casey filed what is believed to be the first lawsuit in the nation against Johnson & Johnson and its subsidiaries related to their implants causing BIA-ALCL (read about that case).